Evidence map›Paper›PMID 32184391›Full record

ArticleNature communications2020

FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis.

Farnaz Shamsi, Ruidan Xue, Tian Lian Huang, Morten Lundh, Yang Liu, Luiz O Leiria, Matthew D Lynes, Elena Kempf, Chih-Hao Wang, Satoru Sugimoto and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Deciphering Uncoupling Proteins in Cellular Homeostasis and Metabolic Health.International journal of biological sciences · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. A Functional Regulatory Variant ofAnimals : an open access journal from MDPI · 2025
    Article
  19. Article
  20. FGF-based drug discovery: advances and challenges.Nature reviews. Drug discovery · 2025
    Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 6 countries.

Farnaz ShamsiSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0003-3506-6950
Ruidan XueSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.
Tian Lian HuangSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0001-7999-1393
Morten LundhSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0003-0918-577X
Yang LiuDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA.
Luiz O LeiriaSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.
Matthew D LynesSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.
Elena KempfSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.
Chih-Hao WangSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0003-1704-1311
Satoru SugimotoSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-2691-3399
Pasquale NigroSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-2918-8356
Kathrin LandgrafCenter for Pediatric Research Leipzig, University Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0002-6878-6033
Tim SchulzSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-8413-3972
Yiming LiDivision of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Brice EmanuelliThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5795-5666
Srinivas KothakotaFive Prime Therapeutics, San Francisco, CA, 94080, USA.
Lewis T WilliamsFive Prime Therapeutics, San Francisco, CA, 94080, USA.
Niels JessenSteno Diabetes Center Aarhus, Aarhus University Hospital, 8200, Aarhus N, Denmark.ORCID http://orcid.org/0000-0001-5613-7274
Steen Bønløkke PedersenSteno Diabetes Center Aarhus, Aarhus University Hospital, 8200, Aarhus N, Denmark.ORCID http://orcid.org/0000-0002-7838-8063
Yvonne BöttcherInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Matthias BlüherDepartment of Internal Medicine (Endocrinology and Nephrology), University of Leipzig, Leipzig, Germany.
Antje KörnerCenter for Pediatric Research Leipzig, University Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0001-6001-0356
Laurie J GoodyearSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-6299-2928
Moosa MohammadiDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, 10016, USA.
C Ronald KahnSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-7583-9228
Yu-Hua TsengSection on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA. yu-hua.tseng@joslin.harvard.edu.ORCID http://orcid.org/0000-0003-2053-9559
Joslin Diabetes Center · USLeipzig University · DEFive Prime Therapeutics (United States) · USNew York University · USSteno Diabetes Centers · DKUniversity of Copenhagen · DKFudan University · CNUniversity of Oslo · NO

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
MECHANISMS OF FGF RECEPTOR REGULATION AND SIGNALINGR01DE013686 · NIDCR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOHAMMADI, MOOSA · 2000 to 2020
$12.3M
Developmental genes, miRNAs and adipose tissueR01DK082659 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 2009 to 2026
$10.7M
Novel Mechanisms of Exercise Training Effects on Glucose HomeostasisR01DK099511 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 2014 to 2026
$6.5M
Role of BMPs in Adipogenesis, Mitochondrial Function and Energy MetabolismR01DK077097 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2007 to 2019
$5.6M
Fibroblast Growth Factor and Energy MetabolismR01DK102898 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2015 to 2024
$4.1M
The Lipidomics of Adipose Tissue ThermogenesisK01DK111714 · NIDDK · MAINEHEALTH · PI LYNES, MATTHEW D · 2017 to 2021
$804k
Telomerase as a Marker of Brown and White Adipose Tissue Stem CellsF32DK102320 · NIDDK · JOSLIN DIABETES CENTER · PI LYNES, MATTHEW D · 2014 to 2014
$53k
NIDCR NIH HHS R01 DE013686NIDDK NIH HHS F32 DK102320NIDDK NIH HHS K01 DK111714NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK077097NIDDK NIH HHS R01 DK082659NIDDK NIH HHS R01 DK099511NIDDK NIH HHS R01 DK102898NIDDK NIH HHS T32 DK007260
6 · The paper itself

Abstract

Uncoupling protein-1 (UCP1) plays a central role in energy dissipation in brown adipose tissue (BAT). Using high-throughput library screening of secreted peptides, we identify two fibroblast growth factors (FGF), FGF6 and FGF9, as potent inducers of UCP1 expression in adipocytes and preadipocytes. Surprisingly, this occurs through a mechanism independent of adipogenesis and involves FGF receptor-3 (FGFR3), prostaglandin-E2 and interaction between estrogen receptor-related alpha, flightless-1 (FLII) and leucine-rich-repeat-(in FLII)-interacting-protein-1 as a regulatory complex for UCP1 transcription. Physiologically, FGF6/9 expression in adipose is upregulated by exercise and cold in mice, and FGF9/FGFR3 expression in human neck fat is significantly associated with UCP1 expression. Loss of FGF9 impairs BAT thermogenesis. In vivo administration of FGF9 increases UCP1 expression and thermogenic capacity. Thus, FGF6 and FGF9 are adipokines that can regulate UCP1 through a transcriptional network that is dissociated from brown adipogenesis, and act to modulate systemic energy metabolism.

Indexed as

AdipogenesisAdipocytes, BrownAdipose Tissue, BrownAnimalsFibroblast Growth Factor 6Fibroblast Growth Factor 9HumansMaleMiceMice, Inbred C57BLObesityThermogenesisUncoupling Protein 1Fgf6 protein, mouseFgf9 protein, mouseFibroblast Growth Factor 6Fibroblast Growth Factor 9Ucp1 protein, mouseUncoupling Protein 1

Identifiers

PMID32184391
PMCPMC7078224
OpenAlexW3012554073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.